METHODS OF TREATING PSORIATIC ARTHRITIS USING IL-17 ANTAGONISTS
Application
US20260077042A1
Kind: A1
Mar 19, 2026
Inventors
Shephard MPOFU, Hanno RICHARDS, Karthinathan THANGAVELU, Matthias MACHACEK
Abstract
The disclosure relates to novel regimens for treating an inflammatory arthritis, e.g., psoriatic arthritis, which employ a therapeutically effective amount of an Interleukin-17 (IL-17) antagonist, e.g., IL-17 binding molecule (e.g., IL-17 antibody or antigen binding fragment thereof, e.g., secukinumab) or IL-17 receptor binding molecule (e.g., IL-17 antibody or antigen binding fragment thereof).
CPC Classifications
A61K 39/3955
A61K 31/519
A61K 45/06
C07K 16/244
A61K 2039/505
A61K 2039/545
A61K 2039/55
C07K 2317/21
C07K 2317/34
C07K 2317/76
C07K 2317/90
Filing Date
2025-11-14
Application No.
19389528